Evidence map›Paper›PMID 40384018›Full record

ArticleThe American journal of psychiatry2025

Familial Risk of Postpartum Psychosis.

Adrianna P Kępińska, Thalia K Robakis, Keith Humphreys, Xiaoqin Liu, René S Kahn, Trine Munk-Olsen, Veerle Bergink, Behrang Mahjani

Abstract read
In one paragraph

Article in The American journal of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Psychedelic therapy and postpartum depression: priorities and prospects.Therapeutic advances in psychopharmacology · 2026
    Review
  4. Sibling Psychiatric Disorders and Risk of Postpartum Psychosis.medRxiv : the preprint server for health sciences · 2025
    Article
  5. Review
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Adrianna P KępińskaSeaver Autism Center for Research and Treatment (Kępińska, Mahjani), Department of Psychiatry (Kępińska, Robakis, Kahn, Bergink, Mahjani), Department of Genetics and Genomic Sciences (Kępińska, Mahjani), Mindich Child Health and Development Institute (Mahjani), and Department of Artificial Intelligence and Human Health (Mahjani), Icahn School of Medicine at Mount Sinai, New York; Department of Medical Epidemiology and Biostatistics (Humphreys, Mahjani) and Department of Molecular Medicine and Surgery (Mahjani), Karolinska Institutet, Stockholm; Department of Clinical Research, Research Unit Children and Adolescent Psychiatry, University of Southern Denmark, Odense (Liu, Munk-Olsen); Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands (Bergink).
Thalia K RobakisSeaver Autism Center for Research and Treatment (Kępińska, Mahjani), Department of Psychiatry (Kępińska, Robakis, Kahn, Bergink, Mahjani), Department of Genetics and Genomic Sciences (Kępińska, Mahjani), Mindich Child Health and Development Institute (Mahjani), and Department of Artificial Intelligence and Human Health (Mahjani), Icahn School of Medicine at Mount Sinai, New York; Department of Medical Epidemiology and Biostatistics (Humphreys, Mahjani) and Department of Molecular Medicine and Surgery (Mahjani), Karolinska Institutet, Stockholm; Department of Clinical Research, Research Unit Children and Adolescent Psychiatry, University of Southern Denmark, Odense (Liu, Munk-Olsen); Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands (Bergink).
Keith HumphreysSeaver Autism Center for Research and Treatment (Kępińska, Mahjani), Department of Psychiatry (Kępińska, Robakis, Kahn, Bergink, Mahjani), Department of Genetics and Genomic Sciences (Kępińska, Mahjani), Mindich Child Health and Development Institute (Mahjani), and Department of Artificial Intelligence and Human Health (Mahjani), Icahn School of Medicine at Mount Sinai, New York; Department of Medical Epidemiology and Biostatistics (Humphreys, Mahjani) and Department of Molecular Medicine and Surgery (Mahjani), Karolinska Institutet, Stockholm; Department of Clinical Research, Research Unit Children and Adolescent Psychiatry, University of Southern Denmark, Odense (Liu, Munk-Olsen); Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands (Bergink).
Xiaoqin LiuSeaver Autism Center for Research and Treatment (Kępińska, Mahjani), Department of Psychiatry (Kępińska, Robakis, Kahn, Bergink, Mahjani), Department of Genetics and Genomic Sciences (Kępińska, Mahjani), Mindich Child Health and Development Institute (Mahjani), and Department of Artificial Intelligence and Human Health (Mahjani), Icahn School of Medicine at Mount Sinai, New York; Department of Medical Epidemiology and Biostatistics (Humphreys, Mahjani) and Department of Molecular Medicine and Surgery (Mahjani), Karolinska Institutet, Stockholm; Department of Clinical Research, Research Unit Children and Adolescent Psychiatry, University of Southern Denmark, Odense (Liu, Munk-Olsen); Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands (Bergink).
René S KahnSeaver Autism Center for Research and Treatment (Kępińska, Mahjani), Department of Psychiatry (Kępińska, Robakis, Kahn, Bergink, Mahjani), Department of Genetics and Genomic Sciences (Kępińska, Mahjani), Mindich Child Health and Development Institute (Mahjani), and Department of Artificial Intelligence and Human Health (Mahjani), Icahn School of Medicine at Mount Sinai, New York; Department of Medical Epidemiology and Biostatistics (Humphreys, Mahjani) and Department of Molecular Medicine and Surgery (Mahjani), Karolinska Institutet, Stockholm; Department of Clinical Research, Research Unit Children and Adolescent Psychiatry, University of Southern Denmark, Odense (Liu, Munk-Olsen); Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands (Bergink).
Trine Munk-OlsenSeaver Autism Center for Research and Treatment (Kępińska, Mahjani), Department of Psychiatry (Kępińska, Robakis, Kahn, Bergink, Mahjani), Department of Genetics and Genomic Sciences (Kępińska, Mahjani), Mindich Child Health and Development Institute (Mahjani), and Department of Artificial Intelligence and Human Health (Mahjani), Icahn School of Medicine at Mount Sinai, New York; Department of Medical Epidemiology and Biostatistics (Humphreys, Mahjani) and Department of Molecular Medicine and Surgery (Mahjani), Karolinska Institutet, Stockholm; Department of Clinical Research, Research Unit Children and Adolescent Psychiatry, University of Southern Denmark, Odense (Liu, Munk-Olsen); Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands (Bergink).
Veerle BerginkSeaver Autism Center for Research and Treatment (Kępińska, Mahjani), Department of Psychiatry (Kępińska, Robakis, Kahn, Bergink, Mahjani), Department of Genetics and Genomic Sciences (Kępińska, Mahjani), Mindich Child Health and Development Institute (Mahjani), and Department of Artificial Intelligence and Human Health (Mahjani), Icahn School of Medicine at Mount Sinai, New York; Department of Medical Epidemiology and Biostatistics (Humphreys, Mahjani) and Department of Molecular Medicine and Surgery (Mahjani), Karolinska Institutet, Stockholm; Department of Clinical Research, Research Unit Children and Adolescent Psychiatry, University of Southern Denmark, Odense (Liu, Munk-Olsen); Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands (Bergink).
Behrang MahjaniSeaver Autism Center for Research and Treatment (Kępińska, Mahjani), Department of Psychiatry (Kępińska, Robakis, Kahn, Bergink, Mahjani), Department of Genetics and Genomic Sciences (Kępińska, Mahjani), Mindich Child Health and Development Institute (Mahjani), and Department of Artificial Intelligence and Human Health (Mahjani), Icahn School of Medicine at Mount Sinai, New York; Department of Medical Epidemiology and Biostatistics (Humphreys, Mahjani) and Department of Molecular Medicine and Surgery (Mahjani), Karolinska Institutet, Stockholm; Department of Clinical Research, Research Unit Children and Adolescent Psychiatry, University of Southern Denmark, Odense (Liu, Munk-Olsen); Department of Psychiatry, Erasmus Medical Center, Rotterdam, the Netherlands (Bergink).

Funding

Developmental effects of antenatal exposure to antipsychoticsR01HD111117 · NICHD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI THALIA K ROBAKIS · 2023 to 2026
$2.5M
Risk architecture of postpartum psychosisR21MH131933 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MAHJANI, BEHRANG · 2023 to 2024
$465k
NICHD NIH HHS R01 HD111117NIMH NIH HHS R21 MH131933
6 · The paper itself

Abstract

objectivePostpartum psychosis is one of the most severe psychiatric conditions, with high risks of suicide and infanticide if untreated. Although genetic factors contribute to the risk of postpartum psychosis, the extent of familial risk remains to be determined. The authors compared relative recurrence risk across different family relationship types, hypothesizing that relative recurrence risk for postpartum psychosis varies by degree of genetic relatedness and is higher in female full siblings than in cousins.

methodsThis cohort study consisted of 1,648,759 women from the Swedish nationwide registers, of whom 2,514 (0.15%) experienced postpartum psychosis within 3 months of their first-ever childbirth. The authors estimated the relative recurrence risk of postpartum psychosis for female full siblings and cousins as a measure of familial risk.

resultsThe relative recurrence risk of postpartum psychosis in full siblings was 10.69 (95% CI=6.60, 16.26) when adjusted for year of and age at childbirth. Although cousins showed an elevated relative recurrence risk, these results did not reach statistical significance (1.78, 95% CI=0.70, 3.62). Despite the higher familial risk of postpartum psychosis among full siblings, the absolute risk for women with an affected sibling was relatively low, estimated at 1.60% within the entire population.

conclusionsThe observed increased risk of postpartum psychosis in full siblings suggests both genetic and shared environmental influences. However, the lack of significant results in cousins hampers a more accurate distinction between these factors. Furthermore, despite increased relative recurrence risk in siblings, their overall likelihood of developing postpartum psychosis remains low. This study underscores the need for further research to better understand the intricate interplay of genetics and shared environment in the development of postpartum psychosis.

Indexed as

Postpartum PeriodPsychotic DisordersPuerperal DisordersAdultCohort StudiesFemaleGenetic Predisposition to DiseaseHumansMaleRecurrenceRegistriesRisk FactorsSiblingsSwedenYoung AdultBipolar and Related DisordersEpidemiologyMood Disorders-PostpartumPsychotic Disorders

Identifiers

PMID40384018
PMCPMC12900257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.